1. Alger JR, Ellingson BM, Ashe-McNalley C, Woodworth DC, Labus JS, Farmer M, Apkarian AV, Johnson KA, Mackey SC, Ness TJ, Deutsch G, Harris RE, Clauw DJ, Glover GH, Huang L, Parrish TB, den Hollander J, Kusek, JW, Mullins C, Mayer EA. Multisite, multimodal neuroimaging of chronic urological pelvic pain: Methodology of the MAPP Research Network. Neuroimage Clin. 2016 Jan;12:65-77. PMCID: PMC4925887
  2. Bhatt SP, Terry NL, Nath H, Zach JA, Tschirren J, Bolding MS, Stinson DS, Wilson CG, Curran-Everett D, Lynch DA, Putcha N, Soler X, Wise RA, Washko GR, Hoffman EA, Foreman MG, Dransfield MT. Genetic Epidemiology of COPD (COPD Gene) Investigators. Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers. JAMA. 2016 Feb 2;315(5):498-505. PMCID: PMC5173387
  3. Deutsch G, Deshpande H, Frolich MH, Lai HH, Ness TJ. Bladder Distension Increases Blood Flow in Pain-Related Brain Structures in Subjects With Interstitial Cystitis. J Urology. 2016 Sep;(3):902–910. PMCID: PMC5014638
  4. de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques. Mol Imaging Biol. 2016 Apr;18(2):232-42. PMID: 26335283
  5. Kim H, Buchsbaum DJ, Zinn KR. A novel imaging biomarker extracted from fluorescence microscopic imaging of TRA-8/DR5 oligomers predicts TRA-8 therapeutic efficacy in breast and pancreatic cancer mouse models. Mol Imaging Biol. 2016 Jun;18(3):325-33. PMID: 26552657
  6. Kim H, Samuel SL, Lopez-Casas PP, Grizzle WE, Hidalgo M, Kovar J, Oelschlager DK, Zinn K, Warram JM, Buchsbaum DJ. SPARC independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic cancer xenografts. Mol Cancer Ther. 2016 Apr;15(4):680-8, 2016. PMID: 26832793
  7. Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, Nguyen QT, Olson JM, Paulsen KD, Rieves D, Sumer BD, Tweedle MF, Vahrmeijer AL, Weichert JP, Wilson BC, Zenn MR, Zinn KR, van Dam GM. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. J Nucl Med. 2016 Jan;57(1):144-50. PMCID: PMC4772735
  8. Szaflarski JP, Lee ST, Allendorfer JB, Gaston T, Knowlton R, Pati S, Ver Hoef LW, Deutsch G. White matter abnormalities in patients with treatment-resistant genetic generalized epilepsies. Med Sci Monitor. 2016 Jun;22:1966-75.
    PMCID: PMC4917325
  9. Sherwood J, Lovas K, Rich M, Yin Q, Lackey K, Bolding MS, Bao Y. Shape-dependent cellular behaviors and relaxivity of iron oxide-based T(1) MRI contrast agents. Nanoscale. 2016 Oct;8(40):17506-17515. PMID: 27714177
  10. Kraguljac NV, Frölich MA, Tran S, White DM, Nichols N, Barton-McArdle A, Reid MA, Bolding MS, Lahti AC. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Mol Psychiatry. 2016 Aug 2. doi: 10.1038/mp.2016.122.
    [Epub ahead of print] PMID: 27480494.
  11. Kasten BB, Azure MT, Schoeb TR, Fisher DR, Zinn KR. Imaging, biodistribution, and toxicology evaluation of 212Pb-TCMC-trastuzumab in nonhuman primates. Nuc Med Biol. 2016 Jul;43(7):391-396. PMID: 27179247
  12. Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Shrestha K, Blume SW. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells. Tumour Biol 2016 Oct;37(10):13247-13264.
    PMCID: PMC5097113
  13. Moore LS, Rosenthal EL, Chung TK, de Boer E, Patel N, Prince AC, Korb ML, Walsh EM, Young ES, Stevens TM, Withrow KP, Morlandt AB, Richman J, Carroll WR, Zinn KR, Warram JM. Characterizing the utilities and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients. J Nucl Med. 2016 Feb;58(2):246-251. PMID: 27587708
  14. Raju SV, Kim H, Byzek S, Tang LP, Trombley JA, Jackson P, Rasmussen L, Wells JM, Libby EF, Dohm E, Winter L, Samuel SL, Zinn KR, Blalock JE, Schoeb TR, Dransfield MT, Rowe SM. A Ferret Model of COPD-Related Chronic Bronchitis. JCI Insight 2016 Sep;1(15):e87536, 2016. [published Sept. 22, 2016] PMCID: PMC5033751
  15. Saadoon A, Ambalavanan N, Zinn K, Ashraf A, MacEwen M, Nicola T, Fanucchi M, Harris W. Effect of Prenatal versus Postnatal Vitamin D Deficiency on Pulmonary Structure and Function in Mice. Am J Respir Cell Mol Biol 2016 Mar;56(3):383-392.
    PMID: 27870560
  16. Moore LS, Rosenthal EL, de Boer E, Prince AC, Patel N, Richman JM, Morlandt AB, Carroll WR, Zinn KR, Warram JM. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation. Mol Imaging Biol. 2016 [Nov 9, 2016; Epub ahead of print] PMID: 27830425.
  17. Liu Y, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ. GH Receptor/PRL Receptor Hetero-multimer is Composed of GH Receptor Homodimers and PRL Receptor Homodimers. Mol Endocrinol. 2016 May; 30(5):504-17. PMCID: PMC4853563
  18. Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Dis Model Mech. 2016 Jul1; 9(7):759-767. PMCID: PMC4958313
  19. Tipirneni KE, Warram JM, Moore LS, Prince A, de Boer E, Jani AH, Wapnir I, Liao JC, Bouvet M, Poultsides G, Behnke N, Hawn MT, Vahrmeijer A, Carroll WR, Zinn KR, Rosenthal EL. Tumor Types Amendable to Fluorescence Contrast-Enhanced Surgery. Ann Surg doi: 10.1097/SLA.0000000000002127. [Dec 30, 2016; Epub ahead of print]
  20. Bandara N, Cherkuri K, Zheleznyak A, Griffith DA, Limberakis C, Tess DA, Chen J, Waterhouse R, Lapi SE. Evaluation of 64Cu and 68Ga Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β-cell Imaging. Mol Imaging and Biol. 2016 Feb;18(1) 90-8, 2016. PMCID: PMC4877185
  21. Wright BD, Whittenberg J, Desai A, DiFelice C, Kenis PJA, Lapi SE, Reichert D. Microfluidic Preparation of an 89Zr-Labeled Trastuzumab Single Patient Dose. J Nucl Med. 2016 May; 57(5):747-52. PMID: 26769862
  22. Lange SES, Zheleznyak A, Studer M, O’Shannessy DJ, Lapi SE, Van Tine BA. Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET Applications. Oncotarget. 2016 Mar;7(11):13082-92. PMCID: PMC4914343
  23. Wooten AL, Lewis BC, Szatkowski DJ, Sultan DH, Abdin KI, Voller TF, Liu Y, Lapi SE. Calibration setting numbers for dose calibrators for the PET isotopes (52)Mn, (64)Cu, (76)Br, (86)Y, (89)Zr, (124)I. Appl Radiat Isot. 2016 Jul;113:89-95. PMID: 27152914
  24. Gordon L, Lapi SE, Anderson C, Schwarz SW; SNMMI Committee on Women in Nuclear Medicine. (2016) Working Together to Advance Women in Nuclear Medicine. J Nucl Med 2016 Sep;57(9):14N. PMID: 27587795
  25. Graaf MD, Marquez BV, Yeh NH, Lapi SE, Moeller KD.(2016) New Methods for the Site-Selective Placement of Peptides on a Microelectrode Array: Probing VEGF-v107 Binding as Proof of Concept. ACS Chem Biol. 2016 Oct;11(10):2829-2837. PMID: 27556638
  26. Nie X, Randolph GJ, Elvington A, Bandara N, Zheleznyak A, Gropler RJ, Woodard PK, Lapi SE. Imaging of Hypoxia in Mouse Atherosclerotic Plaques with (64)Cu-ATSM. Nucl Med Biol. 2016 Sep;43(9):5345-42. PMCID: PMC4992634
  27. Nie X, Laforest R, Elvington A, Randolph GJ, Zheng J, Voller T, Abendschein DR, Lapi SE, Woodard PK. PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model. J Nucl Med. 2016 Dec;57(12):2006-2011. PMCID: PMC4992634
  28. Jin H, Yang H, Zhang Y, Zhange X, Rosenberg AJ, Liu Y, Lapi SE, Tu Z. A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury. J Nucl Cardiol. 2016 Feb; doi:10.1007/s12350-015-0391-1
    [Epub ahead of print]
  29. Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F. [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer. Mol Imaging Biol. 2016 Dec;18(6):952-959. PMCID: PMC5096950